Abstract

BackgroundIn the treatment and follow up of rheumatoid arthritis (RA) patients, it has become more desirable to detect changes in disease activity through telemonitoring, for which patient reported outcomes (PROs)...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Responsiveness and sensitivity of PROMs to change in disease activity status in early and established rheumatoid arthritis.
Agnes E M Looijen ... Pascal H P de Jong
Rheumatology (Oxford, England) | VOL. -
Agnes E M Looijen, et. al.Agnes E M Looijen ... Pascal H P de Jong
04 Apr 2024
AB0291 QUICK ATTAINMENT OF LOW DISEASE ACTIVITY LESSENS THE DISEASE BURDEN OF RHEUMATOID ARTHRITIS IN THE LONG TERM, EVEN WHEN A TREAT-TO-TARGET APPROACH IS APPLIED
M. Vis ... A. Van der Helm – van Mil
Annals of the Rheumatic Diseases | VOL. 82
M. Vis, et. al.M. Vis ... A. Van der Helm – van Mil
30 May 2023
POS0649 BARICITINIB PROVIDES GREATER IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES ACROSS ALL DISEASE ACTIVITY LEVELS COMPARED TO PLACEBO AND ADALIMUMAB IN RHEUMATOID ARTHRITIS
Y. F. Chen ... P. C. Taylor
-
Y. F. Chen, et. al.Y. F. Chen ... P. C. Taylor
01 Jun 2021
Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis.
Bonnie Vlahos ... Generoso Guerra Bautista
Open access rheumatology : research and reviews | VOL. 11
Bonnie Vlahos, et. al.Bonnie Vlahos ... Generoso Guerra Bautista
01 Dec 2019
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Retraction: PKCδ null mutations in a mouse model of osteoarthritis alter osteoarthritic pain independently of joint pathology by augmenting NGF/TrkA-induced axonal outgrowth
-
Annals of the Rheumatic Diseases | VOL. -
--
22 Apr 2024
Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease.
Andrea R Daamen ... Peter E Lipsky
Annals of the rheumatic diseases | VOL. -
Andrea R Daamen, et. al.Andrea R Daamen ... Peter E Lipsky
18 Apr 2024
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events
Dionysis Nikolopoulos ... Dimitrios T Boumpas
Annals of the Rheumatic Diseases | VOL. -
Dionysis Nikolopoulos, et. al.Dionysis Nikolopoulos ... Dimitrios T Boumpas
12 Apr 2024
Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis
Ji-Won Kim ... Jung-Yoon Choe
Annals of the Rheumatic Diseases | VOL. -
Ji-Won Kim, et. al.Ji-Won Kim ... Jung-Yoon Choe
09 Apr 2024
View more papers